Peter Naredi

Professor

University of Gothenburg

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Cancer Biology Cancer Biology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Peter Naredi is a faculty member at the University of Gothenburg, Sweden. His research focuses on clinical oncology, particularly in pancreatic and colorectal cancers, with recent studies exploring biomarkers for high-risk lesions, the impact of surgery-induced immune responses, and innovative approaches to surgical management. He is also involved in the study of signaling pathways affecting cellular responses in cancer and the potential for early detection of pancreatic cancer through blood plasma biomarkers.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Magnus Rizell

Karolinska University Hospital

SWEDEN

View details

Julieta Corral

SPAIN

View details

Per Andersen

DENMARK

View details

Daniel Öhlund

Umea University

SWEDEN

View details

Johan Bourghardt Fagman

University of Gothenburg

SWEDEN

View details

Gunnar C. Hansson

University of Gothenburg

SWEDEN

View details

Josep M Borras

Professor

University of Barcelona

SPAIN

View details

Malin Sund

University of Helsinki

FINLAND

View details

Gautam Kao

Research Engineer (Research Asst. Professor)

Umeå Universitet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Naredi

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Adjunct mucin biomarkers MUC2+MUC5AC and MUC5AC+PSCA in a clinical setting identify and may improve correct selection of high-risk pancreatic lesions for surgery

Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer

High resection rates of colorectal liver metastases after standardized follow-up and multimodal management: an outcome study within the COLOFOL trial

Cisplatin toxicity is counteracted by the activation of the p38/ATF-7 signaling pathway in post-mitotic C. elegans

A proinsulin-dependent interaction between ENPL-1 and ASNA-1 in neurons is required to maintain insulin secretion in C. elegans

Identification of C. elegans ASNA-1 domains and tissue requirements that differentially influence platinum sensitivity and growth control

A Cross-Sectional and Longitudinal Analysis of Pre-Diagnostic Blood Plasma Biomarkers for Early Detection of Pancreatic Cancer

Innovation, value and reimbursement in radiation and complex surgical oncology: Time to rethink

Innovation, value and reimbursement in radiation and complex surgical oncology: Time to rethink

Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trial

Survival and prognostic factors after transplantation, resection and ablation in a national cohort of early hepatocellular carcinoma

Impact of patient, primary tumor and metastatic pattern including tumor location on survival in patients undergoing ablation or resection for colorectal liver metastases: A population-based national cohort study

Collaborators (9)

Magnus Rizell

Julieta Corral

Per Andersen

Daniel Öhlund

Johan Bourghardt Fagman

Gunnar C. Hansson

Josep M Borras

Malin Sund

Gautam Kao

Make your next move.